RAMONA WHITE: Open Payments
NPI 1679060925 · UPPER MARLBORO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 33 payments from 8 companies in 2025. Trend: 2023 $205 · 2024 $429 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $208 |
| Lundbeck LLC | 5 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $63 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
| Alkermes, Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: VRAYLAR, REXULTI, AUSTEDO XR, Auvelity, INGREZZA, ARISTADA, COBENFY.
Industry payments across MD — which companies pay providers there.
